FDA Inspection 1253810 — AAA Pharmaceutical, Inc.

AAA Pharmaceutical, Inc. — FEI 3010027650

The FDA completed an inspection of AAA Pharmaceutical, Inc. on March 28, 2025 in Lumberton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lumberton, NJ (United States)

Citations

IDCFRDescription
191221 CFR 211.166(a)Written program not followed